Helping to Fill the Gaps in Invasive Pneumococcal Disease Protection in Children
Posted
about 2 years ago
by
Lindsay Davis
|
|
|
·Discuss the serious threat of invasive pneumococcal disease (IPD) in US Children
|
·Review clinical data for an option to help protect against IPD in pediatric populations
|
·Discuss CDC guidelines addressing IPD in children
|
|
|
|
|
Multiple timing options for this program are available. As you click on the link above, you will
be able to review program details and select a program time that works best for your schedule.
Merck is pleased to sponsor this program. This program is not an accredited CME program and is not designed to meet any training and/or educational requirements.
|
|
|
CDC, Centers for Disease Control and Prevention; US, United States.
|
|
|
Note: This message was distributed from an email account used for sending messages only. Please do not reply to this message.
|
|
This email communication is from Merck Sharp & Dohme LLC. Please manage your email preferences or unsubscribe anytime by clicking here. If you have trouble accessing this link, please send an email to merck_privacy_office@merck.com with a subject line of Email Opt-Out Request – 2022-PVC-T000038406.
|
|
Copyright © 2022 Merck & Co., Inc., Rahway, NJ, USA and its affiliates. All rights reserved.
|
|
Please read our Privacy Policy to learn more about how Merck protects personal information about you.
|
|
Merck Privacy Office, 351 N Sumneytown Pike, UG4B-24, North Wales, PA 19454, USA
|
|
US-PVC-01008 10/22
|
|
|
